Evidence map›Paper›PMID 42597566›Full record

ArticleOpen forum infectious diseases2026

Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons.

Zeba Nauroz, Prasanthy Balasubramanian, Moreno Rodrigues, Shreya Arondekar, Isabella Sengsouk, Camille Hage, Maggie Chahoud, Xori Green, Woudase Gallo, Yolanda Eby and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zeba NaurozDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Prasanthy BalasubramanianDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0009-0002-4949-4286
Moreno RodriguesDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shreya ArondekarDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0009-0002-8355-3681
Isabella SengsoukDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Camille HageDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-6652-0725
Maggie ChahoudDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-5190-2985
Xori GreenDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Woudase GalloDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yolanda EbyDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Aaron A R TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
William A WerbelDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0003-2943-5895
Andrew H KarabaDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0003-2785-317X

Funding

Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant RecipientsR01AI190359 · NIAID · JOHNS HOPKINS UNIVERSITY · PI William Werbel · 2025 to 2026
$2.9M
The Impact of Systemic Immunosuppression on RSV Antibody Generation and Effector Functions After VaccinationR01AI190195 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Andrew Hoover Karaba · 2025 to 2026
$1.6M
Modulation of Herpes Simplex Virus Pathogenesis by Leucine Rich Repeat Kinase 2K08AI156021 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KARABA, ANDREW HOOVER · 2021 to 2025
$994k
The Landscape of Serious Infections following Kidney Transplantation in People Living with HIVK23AI157893 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WERBEL, WILLIAM · 2021 to 2025
$847k
NIAID NIH HHS K08 AI156021NIAID NIH HHS K23 AI157893NIAID NIH HHS R01 AI190195NIAID NIH HHS R01 AI190359
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) antibody durability in immunosuppressed persons following RSV vaccination is unknown. In this observational cohort of immunosuppressed persons, peak responses occurred 1 month after vaccination, without significant waning by 6 months; adjuvanted vaccine recipients had higher responses. This suggests RSV antibody durability of at least 6 months and potential augmentation by adjuvanted vaccine.

Indexed as

immunocompromisedRSVvaccine

Identifiers

PMID42597566
PMCPMC13469694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.